(Q39947451)

15 September 2017

title

SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug-target interactions and drug repositioning (English)

1 reference

15 September 2017

0 references

1 reference

Feixiong Cheng

2

0 references

author name string

Zengrui Wu

1

1 reference

15 September 2017

Jie Li

3

1 reference

15 September 2017

Weihua Li

4

1 reference

15 September 2017

Guixia Liu

5

1 reference

15 September 2017

Yun Tang

6

1 reference

15 September 2017

publication date

4 March 2016

1 reference

Briefings in Bioinformatics

15 September 2017

published in

1 reference

15 September 2017

volume

18

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

333-347

1 reference

Target-based drug discovery: is something wrong?

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Network pharmacology: the next paradigm in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Prediction of human genes and diseases targeted by xenobiotics using predictive toxicogenomic-derived models (PTDMs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Computational prediction of microRNA networks incorporating environmental toxicity and disease etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Exploiting drug-disease relationships for computational drug repositioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

TarFisDock: a web server for identifying drug targets with docking approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Prediction of chemical-protein interactions: multitarget-QSAR versus computational chemogenomic methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Prediction of drug-target interaction networks from the integration of chemical and genomic spaces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Relating protein pharmacology by ligand chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Predicting new molecular targets for known drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Prediction of drug-target interactions and drug repositioning via network-based inference

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Prediction of chemical-protein interactions network with weighted network-based inference method

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Drug-target interaction prediction through domain-tuned network-based inference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Drug-target interaction prediction by random walk on the heterogeneous network

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

The purchasable chemical space: a detailed picture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

How many drug targets are there?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Clinical development success rates for investigational drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Estimation of ADME properties with substructure pattern recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Extracting sets of chemical substructures and protein domains governing drug-target interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Chemical substructures that enrich for biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

ChEMBL: a large-scale bioactivity database for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

DrugBank 3.0: a comprehensive resource for 'omics' research on drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Analysis of in vitro bioactivity data extracted from drug discovery literature and patents: Ranking 1654 human protein targets by assayed compounds and molecular scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

In silico assessment of chemical biodegradability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Extended-connectivity fingerprints

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Chemical structural novelty: on-targets and off-targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Large-scale chemical similarity networks for target profiling of compounds identified in cell-based chemical screens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

FXR antagonism of NSAIDs contributes to drug-induced liver injury identified by systems pharmacology approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

UniProt: the Universal Protein knowledgebase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Comparative Toxicogenomics Database: a knowledgebase and discovery tool for chemical-gene-disease networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Cytoscape: a software environment for integrated models of biomolecular interaction networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Cyclooxygenase 2: a molecular target for cancer prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Retroperitoneal teratoma with somatic malignant transformation: a papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Antitumor effect of meclofenamic acid on human androgen-independent prostate cancer: a preclinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Crystal Structures of Three Classes of Non-Steroidal Anti-Inflammatory Drugs in Complex with Aldo-Keto Reductase 1C3

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Crystal structures of prostaglandin D(2) 11-ketoreductase (AKR1C3) in complex with the nonsteroidal anti-inflammatory drugs flufenamic acid and indomethacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Acetaminophen-induced differentiation of human breast cancer stem cells and inhibition of tumor xenograft growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Cyclin-dependent kinase pathways as targets for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

CDK2 and mTOR are direct molecular targets of isoangustone A in the suppression of human prostate cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Carprofen induction of p75NTR-dependent apoptosis via the p38 mitogen-activated protein kinase pathway in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Involvement of cell cycle regulatory proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Adverse drug events: database construction and in silico prediction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

Federalist principles for healthcare data networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

PharmGKB: the Pharmacogenetics Knowledge Base

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBIB%2FBBW012

21 January 2018

Identifiers

DOI

10.1093/BIB/BBW012

1 reference

15 September 2017

DBLP publication ID

journals/bib/WuCLLLT17

1 reference

DBLP Dataset 2021-01-02

28 January 2021

1 reference